1. Home
  2. CAN vs INBX Comparison

CAN vs INBX Comparison

Compare CAN & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CAN
  • INBX
  • Stock Information
  • Founded
  • CAN 2013
  • INBX 2010
  • Country
  • CAN Singapore
  • INBX United States
  • Employees
  • CAN N/A
  • INBX N/A
  • Industry
  • CAN Semiconductors
  • INBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CAN Technology
  • INBX Health Care
  • Exchange
  • CAN Nasdaq
  • INBX Nasdaq
  • Market Cap
  • CAN 330.5M
  • INBX 345.8M
  • IPO Year
  • CAN 2019
  • INBX 2020
  • Fundamental
  • Price
  • CAN $0.82
  • INBX $26.65
  • Analyst Decision
  • CAN Strong Buy
  • INBX Hold
  • Analyst Count
  • CAN 6
  • INBX 2
  • Target Price
  • CAN $2.50
  • INBX N/A
  • AVG Volume (30 Days)
  • CAN 24.9M
  • INBX 106.0K
  • Earning Date
  • CAN 08-14-2025
  • INBX 11-13-2025
  • Dividend Yield
  • CAN N/A
  • INBX N/A
  • EPS Growth
  • CAN N/A
  • INBX N/A
  • EPS
  • CAN N/A
  • INBX N/A
  • Revenue
  • CAN $345,360,000.00
  • INBX $1,400,000.00
  • Revenue This Year
  • CAN $90.25
  • INBX $563.00
  • Revenue Next Year
  • CAN $42.94
  • INBX $230.77
  • P/E Ratio
  • CAN N/A
  • INBX N/A
  • Revenue Growth
  • CAN 82.40
  • INBX N/A
  • 52 Week Low
  • CAN $0.53
  • INBX $10.81
  • 52 Week High
  • CAN $3.27
  • INBX $30.23
  • Technical
  • Relative Strength Index (RSI)
  • CAN 61.02
  • INBX 53.30
  • Support Level
  • CAN $0.77
  • INBX $26.19
  • Resistance Level
  • CAN $0.85
  • INBX $28.86
  • Average True Range (ATR)
  • CAN 0.04
  • INBX 1.35
  • MACD
  • CAN 0.01
  • INBX -0.39
  • Stochastic Oscillator
  • CAN 83.27
  • INBX 11.39

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: